$ASRT
Assertio Holdings, Inc.

2021 Q4 Form 10-K Financial Statement

#000180866522000012 Filed on March 10, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $33.33M $111.0M $30.20M
YoY Change 10.36% 4.46% -48.99%
Cost Of Revenue $4.896M $15.83M $6.800M
YoY Change -28.0% -20.33% 161.54%
Gross Profit $28.43M $95.18M $23.40M
YoY Change 21.5% 10.16% -58.73%
Gross Profit Margin 85.31% 85.74% 77.48%
Selling, General & Admin $13.28M $56.56M $23.10M
YoY Change -42.53% -45.79% 0.87%
% of Gross Profit 46.69% 59.42% 98.72%
Research & Development $0.00 $0.00 $200.0K
YoY Change -100.0% -100.0% -96.43%
% of Gross Profit 0.0% 0.0% 0.85%
Depreciation & Amortization $7.379M $29.08M $6.900M
YoY Change 6.94% 10.01% -73.15%
% of Gross Profit 25.95% 30.55% 29.49%
Operating Expenses $20.45M $56.56M $29.90M
YoY Change -31.6% -47.89% -44.53%
Operating Profit $7.981M $9.424M -$6.500M
YoY Change -222.78% -111.47% -332.14%
Interest Expense -$2.437M $10.22M $9.600M
YoY Change -125.39% -35.83% -245.45%
% of Operating Profit -30.54% 108.45%
Other Income/Expense, Net -$504.0K -$9.977M -$1.800M
YoY Change -72.0% -127.23% -127.27%
Pretax Income $5.040M -$553.0K -$35.30M
YoY Change -114.28% -98.78% -82.13%
Income Tax $434.0K $700.0K -$11.00M
% Of Pretax Income 8.61%
Net Earnings $4.606M -$1.281M -$24.40M
YoY Change -118.88% -95.45% -87.33%
Net Earnings / Revenue 13.82% -1.15% -80.79%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share $102.3K -$0.03 -$813.3K
COMMON SHARES
Basic Shares Outstanding 44.63M shares 43.17M shares 107.2M shares
Diluted Shares Outstanding 43.17M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.81M $36.81M $20.80M
YoY Change 76.97% 76.97% -50.59%
Cash & Equivalents $36.81M $36.81M $20.79M
Short-Term Investments
Other Short-Term Assets $14.84M $14.84M $17.40M
YoY Change -14.72% -14.72% 16.78%
Inventory $7.489M $7.489M $11.71M
Prepaid Expenses
Receivables $44.36M $44.36M $44.35M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $103.5M $103.5M $94.25M
YoY Change 9.81% 9.75% -9.33%
LONG-TERM ASSETS
Property, Plant & Equipment $1.527M $2.262M $2.437M
YoY Change -37.34% -52.88% -30.31%
Goodwill
YoY Change
Intangibles $216.1M $200.1M
YoY Change 7.98% -50.05%
Long-Term Investments $1.579M $1.579M $1.600M
YoY Change -1.31% -1.31% -87.79%
Other Assets $5.468M $3.154M $6.501M
YoY Change -15.89% 21.31% 6.17%
Total Long-Term Assets $223.0M $223.0M $209.0M
YoY Change 6.71% 6.72% -50.61%
TOTAL ASSETS
Total Short-Term Assets $103.5M $103.5M $94.25M
Total Long-Term Assets $223.0M $223.0M $209.0M
Total Assets $326.5M $326.5M $303.3M
YoY Change 7.67% 7.66% -42.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.685M $6.685M $14.81M
YoY Change -54.86% -54.83% -8.55%
Accrued Expenses $14.70M $69.34M $28.86M
YoY Change -49.07% -30.1% 52.33%
Deferred Revenue $300.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $12.17M $12.17M $11.94M
YoY Change 1.94% 2.3% -85.07%
Total Short-Term Liabilities $135.0M $135.0M $132.7M
YoY Change 1.76% 1.75% -28.1%
LONG-TERM LIABILITIES
Long-Term Debt $61.32M $61.32M $72.16M
YoY Change -15.02% -15.07% -73.4%
Other Long-Term Liabilities $4.636M $27.80M $11.14M
YoY Change -58.38% -35.21% -15.83%
Total Long-Term Liabilities $65.96M $89.11M $83.30M
YoY Change -20.82% -22.58% -70.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $135.0M $135.0M $132.7M
Total Long-Term Liabilities $65.96M $89.11M $83.30M
Total Liabilities $224.1M $224.1M $247.8M
YoY Change -9.54% -9.55% -47.2%
SHAREHOLDERS EQUITY
Retained Earnings -$429.2M -$427.9M
YoY Change 0.3% 7.04%
Common Stock $4.000K $3.000K
YoY Change 33.33% -62.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $102.4M $102.4M $55.51M
YoY Change
Total Liabilities & Shareholders Equity $326.5M $326.5M $303.3M
YoY Change 7.67% 7.66% -42.47%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $4.606M -$1.281M -$24.40M
YoY Change -118.88% -95.45% -87.33%
Depreciation, Depletion And Amortization $7.379M $29.08M $6.900M
YoY Change 6.94% 10.01% -73.15%
Cash From Operating Activities $4.131M $5.523M -$6.000M
YoY Change -168.85% -108.42% -175.95%
INVESTING ACTIVITIES
Capital Expenditures -$53.00K $53.00K $0.00
YoY Change 430.0%
Acquisitions
YoY Change
Other Investing Activities -$18.47M -$18.47M $0.00
YoY Change -103.6%
Cash From Investing Activities -$18.53M -$18.53M $0.00
YoY Change -103.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $44.86M
YoY Change 50878.41%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.522M $29.03M -8.000M
YoY Change -5.97% -106.19% -59.8%
NET CHANGE
Cash From Operating Activities 4.131M $5.523M -6.000M
Cash From Investing Activities -18.53M -$18.53M 0.000
Cash From Financing Activities -7.522M $29.03M -8.000M
Net Change In Cash -21.92M $16.02M -14.00M
YoY Change 56.54% -175.16% 16.67%
FREE CASH FLOW
Cash From Operating Activities $4.131M $5.523M -$6.000M
Capital Expenditures -$53.00K $53.00K $0.00
Free Cash Flow $4.184M $5.470M -$6.000M
YoY Change -169.73% -108.34% -175.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3360000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2770000 USD
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001808665
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39294
CY2021 dei Entity Registrant Name
EntityRegistrantName
ASSERTIO HOLDINGS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0598378
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
100 South Saunders Road
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Lake Forest
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60045
CY2021 dei City Area Code
CityAreaCode
224
CY2021 dei Local Phone Number
LocalPhoneNumber
419‑7106
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2021 dei Trading Symbol
TradingSymbol
ASRT
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
68400000 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45331803 shares
CY2021 dei Auditor Firm
AuditorFirmId
248
CY2020 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2021 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2020 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2020 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36810000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20786000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44361000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44350000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
7489000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
11712000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14838000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28864000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17406000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
103498000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
94254000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1527000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2437000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
216054000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
200082000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5468000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6501000 USD
CY2021Q4 us-gaap Assets
Assets
326547000 USD
CY2020Q4 us-gaap Assets
Assets
303274000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6685000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14808000 USD
CY2021Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
52662000 USD
CY2020Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
63114000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14699000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11138000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
224133000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
135019000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
247760000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12174000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11942000 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
14500000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
6776000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34299000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7182000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
132686000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61319000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72160000 USD
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
23159000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
31776000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4636000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44640444 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44640444 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28392149 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28392149 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
531636000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
483456000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-429226000 USD
CY2020 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
22931000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-427945000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
102414000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
55514000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
326547000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
303274000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111014000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106275000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15832000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19872000 USD
CY2021 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
0 USD
CY2020 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
4213000 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56555000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
104324000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28114000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24783000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
17432000 USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
1089000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
17806000 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
101590000 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
188430000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
9424000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-82155000 USD
CY2021 us-gaap Interest Expense
InterestExpense
10220000 USD
CY2020 us-gaap Interest Expense
InterestExpense
15926000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
243000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3225000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-56113000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9977000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36642000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-553000 USD
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
87000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45513000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
728000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17369000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1281000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1281000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-28144000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28144000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43169000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26209000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43169000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26209000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
57958000 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
11626000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10924000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-28144000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
55514000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193000 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44861000 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-418000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3545000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1281000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
102414000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-1281000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-28144000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29077000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26431000 USD
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
194000 USD
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5680000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3545000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
10924000 USD
CY2021 asrt Provision For Inventory And Other Assets
ProvisionForInventoryAndOtherAssets
1368000 USD
CY2020 asrt Provision For Inventory And Other Assets
ProvisionForInventoryAndOtherAssets
3817000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
17432000 USD
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1588000 USD
CY2021 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
0 USD
CY2020 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
-8424000 USD
CY2021 asrt Fair Value Adjustment Gain Loss Of Assets And Liabilities
FairValueAdjustmentGainLossOfAssetsAndLiabilities
-3913000 USD
CY2020 asrt Fair Value Adjustment Gain Loss Of Assets And Liabilities
FairValueAdjustmentGainLossOfAssetsAndLiabilities
-5129000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19800000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4268000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
291000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3079000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10797000 USD
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-522000 USD
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
8973000 USD
CY2021 asrt Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Employee Related Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingEmployeeRelatedLiabilities
-28699000 USD
CY2020 asrt Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Employee Related Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingEmployeeRelatedLiabilities
-36479000 USD
CY2021 asrt Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-10452000 USD
CY2020 asrt Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-29066000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5523000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65572000 USD
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2020 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
7585000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000 USD
CY2021 asrt Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
18472000 USD
CY2020 asrt Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
0 USD
CY2021 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 USD
CY2020 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
6000000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18525000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
512801000 USD
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4807000 USD
CY2020 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3016000 USD
CY2021 asrt Payment Of Royalty Rights Obligation
PaymentOfRoyaltyRightsObligation
968000 USD
CY2020 asrt Payment Of Royalty Rights Obligation
PaymentOfRoyaltyRightsObligation
500000 USD
CY2021 us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
0 USD
CY2020 us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
171775000 USD
CY2021 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
CY2020 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
10000000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
44861000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
88000 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
193000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
418000 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
866000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29026000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-468550000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16024000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21321000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20786000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42107000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36810000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20786000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1136000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
10124000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
17598000 USD
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
26021000 USD
CY2020 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
CY2021Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
13100000 USD
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
5650000 shares
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.48
CY2021Q1 asrt Sale Of Stock Consideration Received On Transaction Gross
SaleOfStockConsiderationReceivedOnTransactionGross
14000000 USD
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
8750000 shares
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
3.92
CY2021Q1 asrt Sale Of Stock Consideration Received On Transaction Gross
SaleOfStockConsiderationReceivedOnTransactionGross
34300000 USD
CY2021Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
32200000 USD
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Reclassification</span></div><div><span><br/></span></div><div style="text-indent:32.39pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company made certain reclassifications within Total Revenues related to product sales adjustments for previously divested products. Product sales adjustments for previously divested products were reclassified from Product sales, net to Other revenue on the Consolidated Statements of Comprehensive Income, which impacted previously reported amounts for the year ended December 31, 2020. The reclassifications were made so the line item Product sales, net would reflect net sales of the Company’s current commercialized products. Prior period results were recast to conform with these changes and resulted in an increase to Other revenue and an equal and offsetting decrease to Product sales, net of $1.4 million for the year ended December 31, 2020, respectively. Total net revenue as previously reported remains unchanged.</span></div>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates are used when accounting for amounts recorded in connection with acquisitions, including initial fair value determinations of assets and liabilities as well as subsequent fair value measurements. Additionally, estimates are used in determining items such as product returns, rebates, evaluation of impairment of intangible assets, fair value of contingent consideration obligation and taxes on income. Although management believes these estimates are based upon reasonable assumptions within the bounds of its knowledge of the Company, actual results could differ materially from these estimates.</span></div>
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021 asrt Product Return Period Prior To Expiration Date
ProductReturnPeriodPriorToExpirationDate
P6M
CY2021 asrt Product Return Period After Expiration Date
ProductReturnPeriodAfterExpirationDate
P12M
CY2021 asrt Product Return Period Prior To Expiration Date
ProductReturnPeriodPriorToExpirationDate
P6M
CY2021 asrt Cash Discount To Customer For Prompt Payment As Percentage Of Sales Price
CashDiscountToCustomerForPromptPaymentAsPercentageOfSalesPrice
20
CY2021 asrt Discount Reimbursement Period After Filling Of Prescription Subject To Discount
DiscountReimbursementPeriodAfterFillingOfPrescriptionSubjectToDiscount
P1M
CY2021Q4 asrt Accounts Receivable Related To Product Sales
AccountsReceivableRelatedToProductSales
43800000 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1800000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
400000 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of RiskThe Company is subject to credit risk from its accounts receivable related to product sales.
CY2020Q2 us-gaap Share Price
SharePrice
3.60
CY2020Q4 asrt Accounts Receivable Related To Product Sales
AccountsReceivableRelatedToProductSales
40800000 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111014000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106275000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
300000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44361000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44350000 USD
CY2021Q4 asrt Accounts Receivable Allowance For Cash Discount
AccountsReceivableAllowanceForCashDiscount
900000 USD
CY2020Q4 asrt Accounts Receivable Allowance For Cash Discount
AccountsReceivableAllowanceForCashDiscount
1300000 USD
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1242000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1136000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
823000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1340000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5424000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9236000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
7489000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
11712000 USD
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3700000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2300000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13276000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13223000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11749000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10786000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1527000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2437000 USD
CY2021 us-gaap Depreciation
Depreciation
1000000 USD
CY2020 us-gaap Depreciation
Depreciation
1600000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
316096000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
100042000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
216054000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
272010000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
71928000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
200082000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28100000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24800000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
32406000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
23924000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
23924000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
23924000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
111876000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
216054000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
17400000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
735000 USD
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
1579000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
1579000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1955000 USD
CY2021Q4 asrt Prepaid Expense And Deposit Assets Noncurrent
PrepaidExpenseAndDepositAssetsNoncurrent
2456000 USD
CY2020Q4 asrt Prepaid Expense And Deposit Assets Noncurrent
PrepaidExpenseAndDepositAssetsNoncurrent
1936000 USD
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
698000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1031000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5468000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6501000 USD
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1900000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1900000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4122000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5498000 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
828000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
8744000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8062000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12829000 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1687000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1793000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14699000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28864000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
73493000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
84118000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
16000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
73493000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
84102000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12174000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11942000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61319000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72160000 USD
CY2021 asrt Amortization Of Debt Issuance Costs And Discounts And Royalty Rights
AmortizationOfDebtIssuanceCostsAndDiscountsAndRoyaltyRights
194000 USD
CY2020 asrt Amortization Of Debt Issuance Costs And Discounts And Royalty Rights
AmortizationOfDebtIssuanceCostsAndDiscountsAndRoyaltyRights
5680000 USD
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
10220000 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
15925000 USD
CY2021 us-gaap Severance Costs1
SeveranceCosts1
900000 USD
CY2021 us-gaap Other Restructuring Costs
OtherRestructuringCosts
200000 USD
CY2021 us-gaap Severance Costs1
SeveranceCosts1
876000 USD
CY2020 us-gaap Severance Costs1
SeveranceCosts1
15705000 USD
CY2021 us-gaap Other Restructuring Costs
OtherRestructuringCosts
213000 USD
CY2020 us-gaap Other Restructuring Costs
OtherRestructuringCosts
2101000 USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
1089000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
17806000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
3763000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
17806000 USD
CY2020 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-594000 USD
CY2020 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
1888000 USD
CY2020 us-gaap Payments For Restructuring
PaymentsForRestructuring
10343000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
8744000 USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
1089000 USD
CY2021 us-gaap Payments For Restructuring
PaymentsForRestructuring
9005000 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
828000 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
800000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
8700000 USD
CY2021 asrt Lessee Operating Lease Number Of Subleases
LesseeOperatingLeaseNumberOfSubleases
1 segment
CY2021Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
898000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
3151000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2799000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3004000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1978000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2683000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
397000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2815000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2375000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5498000 USD
CY2021Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
800000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.078
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1983000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
421000 USD
CY2021Q4 asrt Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2404000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
29000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2375000 USD
CY2021Q4 asrt Purchase Obligation Percentage
PurchaseObligationPercentage
0.75
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
3400000 USD
CY2021 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
10600000 USD
CY2021Q1 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
5000000 USD
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 USD
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3545000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10924000 USD
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 USD
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 USD
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
8750000 shares
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
3.92
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.11
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.64
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
72750 shares
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200000 USD
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
5650000 shares
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.48
CY2021Q1 asrt Sale Of Stock Consideration Received On Transaction Gross
SaleOfStockConsiderationReceivedOnTransactionGross
14000000 USD
CY2021Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
13100000 USD
CY2021Q1 asrt Sale Of Stock Consideration Received On Transaction Gross
SaleOfStockConsiderationReceivedOnTransactionGross
34300000 USD
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
400000 USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
72750 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1281000 USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2021Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
32200000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
6400000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
1200000 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
1500000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
1200000 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
1500000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0016
CY2021 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
392095 shares
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-28144000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43169000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26209000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1281000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-28144000 USD
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43169000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26209000 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2917000 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4699000 shares
CY2019Q4 asrt Disposal Group Including Discontinued Operations Inventory Transfer
DisposalGroupIncludingDiscontinuedOperationsInventoryTransfer
9000000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-574000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-45327000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
21000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-186000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-553000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45513000 USD
CY2020Q4 asrt Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1248000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
124000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-9100000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
387000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
155000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
511000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-8945000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-7037000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
217000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1387000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
217000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8424000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
728000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17369000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-116000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9558000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
242000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
276000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
3661000 USD
CY2021 asrt Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount
207000 USD
CY2020 asrt Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount
818000 USD
CY2021 asrt Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount
0 USD
CY2020 asrt Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount
451000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2131000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-13029000 USD
CY2021 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
233000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-190000 USD
CY2021 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
63000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
0 USD
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
2330000 USD
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 USD
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
26000 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
202000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
728000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17369000 USD
CY2021Q4 asrt Cares Act Estimated Tax Refund
CARESActEstimatedTaxRefund
8300000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17400000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
78085000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
81471000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2813000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2999000 USD
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1315000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
19800000 USD
CY2021Q4 asrt Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
545000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
103906000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
20652000 USD
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
15147000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
17385000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
22635000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
16812000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
168000 USD
CY2020Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
15496000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
119160000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
126541000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101775000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
21739000 USD
CY2021Q4 asrt Deferred Tax Liability Convertible Debt
DeferredTaxLiabilityConvertibleDebt
228000 USD
CY2020Q4 asrt Deferred Tax Liability Convertible Debt
DeferredTaxLiabilityConvertibleDebt
459000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
349000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
437000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
172000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101800000 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2100000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101800000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13100000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
103900000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4033000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
194000 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
2000 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
124000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4101000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4101000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4100000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4100000 USD
CY2021Q4 asrt Accounts Receivable Allowance For Cash Discount
AccountsReceivableAllowanceForCashDiscount
900000 USD
CY2020Q4 asrt Accounts Receivable Allowance For Cash Discount
AccountsReceivableAllowanceForCashDiscount
1300000 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2100000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13100000 USD

Files In Submission

Name View Source Status
0001808665-22-000012-index-headers.html Edgar Link pending
0001808665-22-000012-index.html Edgar Link pending
0001808665-22-000012.txt Edgar Link pending
0001808665-22-000012-xbrl.zip Edgar Link pending
asrt-20211231.htm Edgar Link pending
asrt-20211231.xsd Edgar Link pending
asrt-20211231_cal.xml Edgar Link unprocessable
asrt-20211231_def.xml Edgar Link unprocessable
asrt-20211231_htm.xml Edgar Link completed
asrt-20211231_lab.xml Edgar Link unprocessable
asrt-20211231_pre.xml Edgar Link unprocessable
exhibit1012toddsmithsepara.htm Edgar Link pending
exhibit1013markstrobecksep.htm Edgar Link pending
exhibit102-managementconti.htm Edgar Link pending
exhibit107-amendedandresta.htm Edgar Link pending
exhibit11-salesagreementxr.htm Edgar Link pending
exhibit21-assetpurchaseagr.htm Edgar Link pending
exhibit211-subsidiaries2.htm Edgar Link pending
exhibit231-gtconsent.htm Edgar Link pending
exhibit232-eyconsent.htm Edgar Link pending
exhibit311-fy2021.htm Edgar Link pending
exhibit312-fy2021.htm Edgar Link pending
exhibit321-fy2021.htm Edgar Link pending
exhibit322-fy2021.htm Edgar Link pending
exhibit43-secondsupplement.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending